IkappaB kinase epsilon: a potential therapeutic target for obesity (and nonalcoholic fatty liver disease)?
Hepatology
.
2010 Jan;51(1):336-8.
doi: 10.1002/hep.23459.
Authors
James E Nelson
1
,
Kris V Kowdley
Affiliation
1
Benaroya Research Institute and Center for Liver Disease, Digestive Disease Institute, Virginia Mason Medical Center, Seattle, WA, USA.
PMID:
20034032
DOI:
10.1002/hep.23459
No abstract available
Publication types
Comment
Grants and funding
K24 DK002957/DK/NIDDK NIH HHS/United States